
Receptor Subtypes by Bupropion, Phencyclidine, and Ibogaine.
: J Pharmacol Exp Ther 1999 Jan 1;288(1):88-92
: Noncompetitive Functional Inhibition at Diverse, Human Nicotinic Acetylcholine
: Receptor Subtypes by Bupropion, Phencyclidine, and Ibogaine.
: Fryer JD, Lukas RJ
: Division of Neurobiology, Barrow Neurological Institute, Phoenix, Arizona.
: [Record supplied by publisher]
: Nicotinic acetylcholine receptors (nAChR) are diverse members of the
: neurotransmitter-gated ion channel
: superfamily and play critical roles in chemical signaling throughout the
: nervous system. The present study
: establishes the acute functional effects of bupropion, phencyclidine, and
: ibogaine on two human nAChR
: subtypes. Function of muscle-type nAChR (alpha1betagammadelta) in TE671/RD
: cells or of ganglionic
: nAChR (alpha3beta4alpha5+/-beta2) in SH-SY5Y neuroblastoma cells was measured
: with 86Rb+ efflux assay
: s. Functional blockade of human muscle-type and ganglionic nAChR is produced by
: each of the {*filter*} in the
: low to intermediate micromolar range. Functional blockade is insurmountable by
: increasing agonist
: concentrations in TE671/RD and SH-SY5Y cells for each of these {*filter*},
: suggesting noncompetitive
: inhibition of nAChR function. Based on these findings, we hypothesize that
: nAChR are targets of diverse
: substances of abuse and agents used in anti{*filter*}ion/smoking cessation
: strategies. We also hypothesize that
: nAChR play heretofore underappreciated roles in depression and as targets for
: clinically useful
: antidepressants.
--
Be proud of who you are. You are someone who can make a
difference in this world.